The FDA (Food and Drug Admnistration) has recently upgraded the recall of Alere INRatio and INRatio2 Monitor systems to a Class I recall. This means that there is a probability that using the Alere system will cause serious health consequences or possibly lead to death.
According to the Boston Globe, on at least two occasions in the past decade, Massachusetts pharmacy officials have displayed indifference in their supervision of a concerning Framingham compounding pharmacy (The New England Compounding Center) that is linked to the nationwide meningitis outbreak that has killed
The sister company of Framingham’s New England Compounding Center (NECC) – Ameridose – recalled all of its products on October 31, 2012. According to health officials, the NECC is the source of fungus-contaminated steroid injections that have killed 28 people and sickened at least 363
In 2004, Massachusetts health regulators proposed a formal reprimand for the pharmacy that is currently linked to the deadly nationwide meningitis outbreak – the New England Compounding Center (NECC) in Framingham, Massachusetts. Health officials never delivered the reprimand, however, after the company protested the reprimand
On Monday October 15, U.S. health regulators announced that two other drugs produced by the New England Compounding Center (NECC), of Framingham, Massachusetts, may be linked to the meningitis outbreak. According to the Food and Drug Administration (FDA), there is an ongoing investigation of a
On October 10, an agreement with the Department of Public Health’s Board of Registration in Pharmacy was signed, stating that Ameridose and its distribution partner, Alanaus Pharmaceuticals, are voluntarily shutting down operations until October 22 to allow inspectors the access needed to conduct an investigation.
New England Compounding Center (NECC) shares the same owners as Ameridose, a company licensed and regulated by federal authorities to manufacture medications on a large scale. Until June 2011, Ameridose’ headquarters were right around the corner from NECC in Framingham, Massachusetts. Government investigators have raising
U.S. health officials announced on Monday, October 8, that 13,000 patients in 23 states, including Connecticut, New Hampshire, and Rhode Island, have been exposed to a potentially hazardous steroid treatment manufactured by a Framingham compounding company. The medication has been linked to a national outbreak
Massachusetts and federal health officials have reportedly identified a Framingham pharmacy as the source of injectable steroids that may have infected more than 25 people, four fatally, with a rare form of fungal meningitis. The pharmacy, New England Compounding Center, recalled three lots of Methylprednisolone
The Atkins diet, which is low in carbohydrates and high in proteins, has been shown to increase the risk of heart disease, according to a new study. A research study assessed the diets of more than 43,000 Swedish women ages 30 to 49 during the
Acetaminophen was first approved by the US Food and Drug Administration (FDA) back in 1951 as a safe drug. However, Tylenol, the popular over the counter drug, has now been reported to be a dangerous drug that causes liver damage. A Tylenol lawsuit calls for
After switching her birth control medication to Citracal, 29-year-old Samantha Balzer began to experience symptoms including constant headaches, vomiting, and instability. The young woman said one day, her hand curled into a ball, and when she stood up, her entire right side felt numb. Then,